Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001064349 | SCV001229246 | uncertain significance | not provided | 2024-01-19 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 1476 of the KIAA1549 protein (p.Pro1476Leu). This variant is present in population databases (rs201971426, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with KIAA1549-related conditions. ClinVar contains an entry for this variant (Variation ID: 858471). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV005036370 | SCV005666099 | uncertain significance | Retinitis pigmentosa 86 | 2024-03-18 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV004813680 | SCV005070122 | uncertain significance | Retinal dystrophy | 2022-01-01 | no assertion criteria provided | clinical testing |